This map shows the geographic impact of K D Tutsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K D Tutsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K D Tutsch more than expected).
This network shows the impact of papers produced by K D Tutsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K D Tutsch. The network helps show where K D Tutsch may publish in the future.
Co-authorship network of co-authors of K D Tutsch
This figure shows the co-authorship network connecting the top 25 collaborators of K D Tutsch.
A scholar is included among the top collaborators of K D Tutsch based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with K D Tutsch. K D Tutsch is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Rietbroek, Ron C., Dörthe M. Katschinski, Monique H. Reijers, et al.. (1997). Lack of thermal enhancement for taxanesin vitro. International Journal of Hyperthermia. 13(5). 525–533.36 indexed citations
McGinn, C.J., Keith A. Kunugi, K D Tutsch, et al.. (1996). Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study.. PubMed. 2(8). 1299–305.6 indexed citations
Schiller, Joan H., Barry E. Storer, K D Tutsch, et al.. (1994). A phase I trial of 3-hour infusions of paclitaxel (Taxol) with or without granulocyte colony-stimulating factor.. PubMed. 21(5 Suppl 8). 9–14.16 indexed citations
12.
Chan, Kenneth K., et al.. (1994). Clinical pharmacokinetics of cyclophosphamide and metabolites with and without SR-2508.. PubMed. 54(24). 6421–9.38 indexed citations
Bailey, Howard H., et al.. (1991). Phase I clinical trial of fazarabine as a twenty-four-hour continuous infusion.. PubMed. 51(4). 1105–8.9 indexed citations
Willson, James K. V., Paul H. Fischer, Scot C. Remick, et al.. (1989). Methotrexate and dipyridamole combination chemotherapy based upon inhibition of nucleoside salvage in humans.. PubMed. 49(7). 1866–70.33 indexed citations
18.
Fischer, Paul H., et al.. (1988). Biochemical assessment of the effects of acivicin and dipyridamole given as a continuous 72-hour intravenous infusion.. PubMed. 48(19). 5591–6.13 indexed citations
19.
Grem, Jean L., K D Tutsch, Dona Alberti, et al.. (1987). Phase I study of taxol administered as a short i.v. infusion daily for 5 days.. PubMed. 71(12). 1179–84.92 indexed citations
20.
Earhart, Robert H., K D Tutsch, Jim M. Koeller, et al.. (1982). Pharmacokinetics of (+)-1,2-di(3,5-dioxopiperazin-1-yl)propane intravenous infusions in adult cancer patients.. PubMed. 42(12). 5255–61.28 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.